Subsequent Events (Details) - Subsequent event [member] |
1 Months Ended |
|---|---|
|
Jan. 30, 2019
shares
| |
| Subsequent Events (Textual) | |
| Description of vesting period | Each of the options may be exercised at a price per option of $0.101 per share. The Options shall vest over a period of four years from their date of grant, with 25% of the Options vesting on the first anniversary of the date of grant and the remaining Options vesting equally on a quarterly basis during the three years thereafter. |
| Chairman [Member] | |
| Subsequent Events (Textual) | |
| Options to purchase common stock | 12,319,500 |
| Services agreement, description | Under the Agreement, Mr. Rigby shall be entitled to an annual fee of $70,000 plus VAT, to be paid on a monthly basis and options to purchase 12,319,500 ordinary shares (represented by 246,390 ADSs exercisable at $5.07 per ADS) exercisable at $0.101 per share. |
| Description of vesting period | The options shall have a term of seven years and shall vest upon the earlier of (1) an equity raise of at least US$10 million, in one or more financings, or (2) will vest over a period of four years, with a quarter of the options vesting on January 31, 2020, and the remaining options vesting in equal parts at the end of every quarter thereafter. |
| Description of options exercisable | (i) 9,050,000 options exercisable into total of 9,050,000 ordinary shares to the company's officers, employees and consultants, and (ii) , subject to shareholders approval, 2,000,000 options exercisable into total of 2,000,000 ordinary shares to members of the board of directors, in the following manner: (i) 250,000 options exercisable into 250,000 ordinary shares, to each of Dr. Abraham Havron, Dr. Gili Hart, Dr. Elan Penn, Scott R. Burell and Adi Goldin; and (ii) 750,000 options exercisable into 750,000 ordinary shares to Dr. Wolfgang Ruttenstorfer. |